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1 Introduction 14 
In a recent issue of Clinical Nutrition (1) a sizeable group of knowledgeable ESPEN members 15 
published a consensus report on Diagnostic Criteria for Malnutrition in both clinical and population 16 
setting. To arrive at this report, clinical scientists were chosen to represent the clinical fields of 17 
medicine, surgery, intensive care, oncology and geriatrics. Communication occurred in several ways 18 
and after each step in the procedure confirmation was sought from the participants. Ultimately a 19 
ballot was organized among the members of ESPEN to seek approval of the statements in the report. 20 
Two alternative ways to diagnose malnutrition were formulated. 21 
1. BMI < 18.5 kg/m
2 
 22 
2. Unintentional weight loss > 10% of initial body weight irrespective of time or > 5% in the last 23 
3 months combined with either 24 
a. BMI < 20 kg/m
2 
if < 70 years of age, or BMI < 22 kg/m
2 
if older than 70 years or 25 
b. FFMI < 15 and 17 kg/m
2 
in women and men respectively. 26 
Despite these efforts we have serious concerns regarding the conclusions drawn because they 27 
might add to the confusion rather than bringing clarity. In this commentary we will try to point out 28 
the shortcomings of the present “consensus” in this regard, and propose to stick to the earlier 29 
consensus statements published in 2010, endorsed by ESPEN (2) and ASPEN (3), which included a 30 
rational approach to the definition and assessment of malnutrition. In our opinion this can be 31 
achieved only when etiological factors such as inflammation and under- or overnutrition are 32 
considered. We will restrict this commentary to the undernourished state and its relationship to 33 
malnutrition states. In our opinion, it is not possible to dissociate the ways to diagnose malnutrition 34 
from its definition. 35 
2 Definition of Malnutrition 36 
Part of the confusion in the nutritional world arises from the interpretation of the term 37 
“Definition”. A definition is a precise statement of the nature of a thing or condition. In the nutritional 38 
and metabolic world we specifically want to define nutrition related disorders. Several efforts have 39 
been made in the past to formulate a definition to describe precisely the pathophysiology of 40 
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undernutrition/malnutrition as it is encountered in the majority of individuals considered 41 
malnourished, both in areas with endemic malnutrition and in clinical settings.  42 
A century ago two forms of undernutrition were distinguished in children in areas with endemic 43 
malnutrition. Marasmus was considered to result from lack of both energy and protein, and typically 44 
is characterized by loss of fat free mass and fat mass, without oedema and with relatively normal 45 
visceral proteins including albumin. Kwashiorkor was considered to result specifically from lack of 46 
intake of protein, and its phenomenology included oedema, disturbances in growth and colour of 47 
hair, skin lesions,fatty liver and hypoalbuminemia. The kwashiorkor children showed less growth 48 
retardation suggesting that their malnutrition was of more recent onset.(4) Later research revealed 49 
that this phenomenology was not restricted to children but also occurred in adults.(5) It has been 50 
suggested that the difference in symptomatology in endemic malnutrition resulted from the 51 
development of infectious diarrhoea: chronic in marasmus, acute in kwashiorkor and often occurring 52 
after suffering from measles or malaria (6, 7). More recently, some evidence has been published 53 
from a study of identical twins in Malawi, that differences in the gut microbiome were responsible 54 
for kwashiorkor type malnutrition occurring in one child of a pair of identical twins and marasmic 55 
malnutrition in the other. (8)  Importantly the design of the study helps to confirm that it is unlikely 56 
that differences in diet were responsible for the differences in phenotype. Waterlow also questioned 57 
the postulated role of differing diets. (4) 58 
In the 1960s and 1970s it became increasingly clear that the features of kwashiorkor type 59 
malnutrition in our hospitals were predominantly related to infectious or non-infectious 60 
inflammation (5). In addition, as long ago as the early 1930s Cuthbertson (9) had already pointed out 61 
that the inflammatory effects of trauma included net nitrogen losses.  Although the concepts were 62 
correct and accepted by many clinicians in ESPEN, the nomenclature was not widely applied in 63 
clinical nutrition.  64 
When observing severely malnourished individuals in the developed world as well as those in 65 
areas with endemic malnutrition, it is clear that their functions are impaired in every imaginable 66 
respect.(10-12) Indeed, insufficient food intake can only be considered to be significant when this has 67 
led to functional disturbances. Therefore in the 1980s the concept that diminished function is an 68 
essential element of malnutrition was developed within the ESPEN community (13). The following 69 
definition was presented in courses and congresses: 70 
 71 
1. Malnutrition is a subacute or chronic state of nutrition, in which undernutrition has led to 72 
a change in body composition and diminished function. 73 
 74 
 In the remainder of this manuscript the term “function” encompasses muscle function, cognitive 75 
function and immune function, supporting a host response leading to successful clinical outcome, 76 
appropriate growth in children, regeneration, restored quality of life and long term survival. The 77 
concept was strongly promoted by the BAPEN community (14), who added “clinical outcome” as a 78 
consequence of biological functioning to the definition.  This was included in the ESPEN basic and 79 
advanced courses and in the third edition of the so-called “blue book” (12). In addition both 80 
undernutrition and overnutrition were considered to be part of the malnutrition spectrum, leading to 81 
the following definition: (15)  82 
 83 
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2. Malnutrition is a state of nutrition in which a deficiency or excess (or imbalance) of energy, 84 
protein and other nutrients causes measurable adverse effects on tissue/body form (body 85 
shape, size, composition), body function and clinical outcome. 86 
 87 
A crucial problem with this definition is that there is no linear relationship between deficiency or 88 
excess of nutrients and body composition and function. This is because the state of malnutrition in 89 
clinical practice and in areas with endemic malnutrition is not often exclusively the result of a 90 
deficiency of nutrients. It is also substantially influenced by the presence of disease, chronic infection 91 
and other stressful factors leading to inflammation, which influences body composition, function, 92 
longevity and clinical outcome.(12, 16, 17) It is equally important that the catabolic effects of non-93 
infectious or infectious inflammation cannot be overcome by nutritional support alone. (18) At best a 94 
beneficial healing response may be supported when inflammatory activity is long standing and 95 
cannot be rapidly treated. 96 
 If the nutritional world therefore wants to assess not only whether the individual does not eat or 97 
absorb enough or overfeeds, but also to assess the changes in body composition and functions to 98 
which this has led, then inflammatory status should be taken into account. In this way nutritional 99 
assessment identifies the pathophysiological state of the individual, and also includes assessment of 100 
the risk not to recover well from trauma and disease, and to have a low life expectancy. This is more 101 
relevant in clinical practice. These considerations have been the underlying reasons to attribute the 102 
“mal” in malnutrition to be more than under- or overnutrition but to view it as a syndrome consisting 103 
of inadequate nutrition and inflammation. This led to the following definition (19):   104 
 105 
3. Malnutrition is a subacute or chronic state of nutrition, in which a combination of varying 106 
degrees of under- or overnutrition and inflammatory activity has led to changes in body 107 
composition and diminished function. 108 
 109 
Essentially inflammation has been added, but the other aspects might be adapted according to 110 
definition 2. for instance by adding “clinical outcome”. The definition was included in the ESPEN LLL 111 
module on malnutrition, is included in the fourth edition of the blue book (20), and is consistent with 112 
consensus statements published in JPEN and Clinical Nutrition, endorsed by ASPEN and ESPEN. (2, 3)   113 
3 Diagnosis of Malnutrition 114 
In the Shorter Oxford English Dictionary “diagnosis” is defined as “Determination of a diseased 115 
condition by investigation of its symptoms”. In medicine diagnosing a specific disease or condition 116 
requires identifying the causative micro-organism or other non-infectious causes and the typical 117 
symptoms and sequelae. Along similar lines, diagnosing malnutrition requires identifying the 118 
causative factors, their consequences for body composition and the resulting functional disturbances. 119 
Although in general more severe disease roughly corresponds with more severe inflammation, the 120 
inflammatory activity itself should be assessed specifically because some disease entities, considered 121 
“severe” and which have a major impact on nutritional intake are not associated with severe 122 
inflammation but are largely caused by (semi-)starvation alone. Examples include intestinal pseudo-123 
obstruction, anorexia nervosa, swallowing disorders due to cerebrovascular events or dementia, all 124 
of which can produce a major reduction in nutritional intake, but with variable and sometimes only 125 
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minor systemic inflammation. In these situations nutritional support is far more effective in 126 
preserving muscle mass and body weight than when severe inflammation is present. 127 
Inflammation is a universal reaction to disease, trauma or surgery and, when substantial and 128 
persisting, leads to substantial loss of fat free mass; moreover, it is connected with fluid retention. 129 
Even when fat free mass solids are not yet markedly decreased, pre-existing inflammation negatively 130 
influences host response, healing and survival.(21, 22) This is even truer when dealing with infectious 131 
inflammation. Consequently, it appears mandatory to assess “disease severity” not (only) on the 132 
basis of a formal diagnosis but also on the basis of the consequences of this disease entity for 133 
appetite and food intake, ability to ingest and absorb nutrients, and the inflammatory activity itself, 134 
which may be assessed for instance by general laboratory parameters like haemoglobin, negative 135 
acute phase proteins like albumin and transthyretin (prealbumin), and positive acute phase proteins 136 
such as C-reactive protein (CRP) (13, 23-26). It is noteworthy that disease severity is a component of 137 
almost all scores aiming to screen patients at risk of malnutrition, malnourished patients and those 138 
who will benefit from nutritional support. 139 
Following from these views we have proposed to make this definition more practicable by 140 
weighting the different factors (inflammation, undernutrition) and their effects on outcome in 141 
defined populations, which would then allow assessment of the degree of malnutrition as a risk 142 
factor for outcome of surgical or medical treatment, growth and regeneration or quality of life and 143 
longevity (19). 144 
 145 
4 Questions regarding the Consensus Statement. 146 
The recent consensus statement (1) lacks most of the criteria outlined in the preceding 147 
paragraphs and therefore in our opinion does not meet the requirements for a definition and a 148 
diagnosis. It is rather an agreement as to when to call an individual malnourished, without taking into 149 
consideration its precise nature, causes and consequences. Importantly questions to answer are still 150 
how to define and diagnose malnutrition and how to arrive at consensus. 151 
4.1 How to arrive at consensus? 152 
When we set out to diagnose malnutrition we should first define what it actually is. Intuitively 153 
most of us consider patients in our hospitals, while we also have a vague impression of little children 154 
with swollen bellies and oedematous arms, and especially legs with very little muscle, in areas of the 155 
world with endemic malnutrition. Most of us also know that in both situations this state of 156 
malnutrition is associated with two major characteristics: undernutrition, implying a negative 157 
nutrient balance, and disease. Defining malnutrition in our view is synonymous with defining its 158 
pathophysiology. To this effect we must take the influence of both undernutrition and 159 
infectious/non-infectious inflammation into account, because only a minority of patients is 160 
exclusively undernourished. This is exactly what is claimed in the previous consensus statement 161 
endorsed by ASPEN and ESPEN (2, 3). It should also be emphasized that there is a progressive 162 
negative impact on survival depending on the degree of undernutrition and inflammation, and that 163 
therefore the thresholds which separate well-nourished and malnourished people may be in some 164 
way artificial (27). 165 
The next step is to agree whether we only want to diagnose undernutrition, implying weight loss 166 
due to inadequate intake or digestion and intestinal absorption of food, or if we truly want assess the 167 
state patients/individuals are in with its consequences for body composition and function. If we only 168 
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want to know whether the individual is failing to ingest or absorb enough, we must realize that we 169 
will establish only one of the two major factors leading to diminished functional capacity in most of 170 
the people we treat, without establishing the often overriding influence of inflammation. What is 171 
worse is that we will not be able to set priorities for treatment, and that we will not know what 172 
benefit will be likely to result from nutritional support. The earlier consensus guidelines endorsed by 173 
ASPEN and ESPEN rightly underline that the benefit of nutritional support is blunted in the presence 174 
of severe inflammation, and that this knowledge should lead to prioritizing treatment of 175 
inflammatory causes, notwithstanding instituting nutritional support. Precise assessment, for 176 
instance of inflammatory markers like CRP, orosomucoïd (α1 –glycoprotein acid) and albumin in a 177 
composite approach with (negative) nutrient balance, fat free mass and clinical signs of inflammation 178 
will also permit the determination of whether a patient is improving or deteriorating (28, 29). It is 179 
therefore important to assess the two major elements leading to malnutrition. 180 
A pitfall of the chosen approach described in the new consensus document (1) is that consensus 181 
conferences and voting sessions threaten not to arrive at the truth. If at the time of Galileo a vote 182 
had established whether the sun turns around the earth or vice versa, the consensus would have 183 
been that the earth is the centre of the universe.(30) When talking about science, the experts should 184 
have a decisive influence on the foundations on which an ultimate decision must be based. The 185 
participants in the voting sessions are obviously experts in several fields, but these do not always 186 
include pathophysiology and/or nutritional assessment methods.  187 
 188 
4.2 How to detect nutritional risk and how to diagnose malnutrition? 189 
Several screening methods have been devised, and within ESPEN the Nutritional Risk Screening 190 
(NRS 2002) method has been developed and has become popular (31, 32). It includes weight loss, 191 
diminished nutritional intake, BMI and disease severity. The equally popular MUST score includes 192 
similar elements and is also adequate (33). Of note, abnormalities in these factors are graded 193 
according to their severity. The numbers acquired add up to a score reflecting the risk of 194 
malnourishment. Patient cohorts with a high risk score have been shown to benefit more often from 195 
nutritional support than patient cohorts with a low risk (34). It is a concern that these scores and 196 
others mix causes (diminished food intake, disease severity) and consequences (weight loss, low 197 
BMI). If we wanted to know only whether an individual can generate an optimal immune and healing 198 
response, assessment of muscle, cognitive and immune function would suffice. When we also want 199 
to know what causes a decrease in these functions we must assess the two major causes: nutritional 200 
intake/digestion and/or the presence of inflammation. These last factors give guidance on how to 201 
treat. (Figure 1) 202 
The accuracy of the screening methods and proposed diagnostic methods may also vary 203 
depending on whether we want to predict the outcome of surgery, chemotherapy or other types of 204 
non-nutritional treatment, the effect of nutritional treatment itself, growth and regeneration, long 205 
term survival or to assess quality of life. Consequently, the term “nutritional risk” is confusing 206 
because it is unclear which risks (i.e. risk of malnutrition or risk of nutrition-related complications) 207 
are assessed in the screening methods. 208 
The diagnosis of malnutrition proposed on the basis of the new consensus procedure does 209 
contain BMI and weight loss, and, in principle, fat free mass index (fat free mass corrected for body 210 
size: FFMI). However, in most institutions this index will not be assessed routinely, although 211 
anthropometry and impedance measurements would be feasible. More sophisticated measures like 212 
CT scanning, MRI or DEXA are costly but may be adapted to a simpler and less costly application in 213 
nutritional assessment. Also PET-scanning will become increasingly available. At present these 214 
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methods to assess body composition are not used routinely anywhere, except in research (35). It 215 
should be pointed out however that most cancer patients undergo routine CT scanning to establish 216 
the stage of cancer before treatment and it would only require an adaptation in the software to 217 
obtain a similarly routine measure of fat free mass versus fat mass. Such methods might therefore in 218 
the future be validated and routinely employed in cancer patients, including establishment of normal 219 
values using large cohorts of healthy subjects. 220 
The remaining items to diagnose malnutrition (or its risk) proposed in the consensus statement do 221 
not include food intake, inflammation or function.  Measuring only BMI and weight loss will be far 222 
less discriminative than the NRS 2002 or the MUST (32). It seems to be highly illogical first to use a 223 
risk screening tool that contains a number of crucial elements and subsequently to make the more 224 
precise diagnosis  of malnutrition by assessing only a few of the same  elements. 225 
On a population basis, body weight increases in the course of life until approximately 5-7 years 226 
before death due to an increase in fat mass, while fat free mass starts to decrease after 227 
approximately 30 years of age, leading to a gradual decrease of functional capacity.(36, 37) The 228 
decrease in fat free mass will develop unnoticed when only weight or BMI is taken into account. It is 229 
the result of comorbidity, inadequate composition of the diet, low physical activity, and very likely 230 
also due to the aging process itself and is therefore not completely preventable. Nevertheless, there 231 
are indications that exercise and increased protein intake may be beneficial (38). In the phase of 232 
increasing body weight the proposed diagnostic approach in the consensus statement, assessing only 233 
weight loss and BMI will not detect (the development of) low fat free mass and the resulting loss of 234 
functional abilities. 235 
In another clinical scenario many individuals in younger age groups with sub-acute or chronic 236 
disease lose weight due to the catabolic influence of disease-related inflammation. This leads to 237 
shrinkage of fat free mass, even when nutritional intake is energetically adequate.(39) The 238 
Cederholm’s et al consensus statement (1) on how to diagnose malnutrition will in this situation 239 
mistakenly lead to the conclusion that the individual is malnourished due to inadequate intake. This 240 
situation is even more complex, because weight loss with shrinkage of fat free mass solids may be 241 
obscured by oedema maintaining body weight. This phenomenon will not necessarily be detected by 242 
DEXA, CT scanning, MRI or impedance measurements. Only sophisticated methods like total 243 
potassium or nitrogen measurements would be adequate, but they cannot be performed routinely. 244 
This oedema results from increased capillary leakage caused by disease or trauma related 245 
inflammation and leads to an increase in extravascular interstitial space, and the distribution volume 246 
of albumin.(40) Albumin dilutes in this volume, leading to hypalbuminaemia, which therefore largely 247 
reflects inflammation and also indicates that the concentration of solids in this volume is decreased 248 
compared with healthy states.(25) Further research may establish the validity of hypalbuminaemia as 249 
a correction factor to compute fat free mass solids from morphometric fat free mass as, for example, 250 
measured by CT scanning. Management of such patients requires full understanding of the 251 
pathophysiology leading to the changes in body composition. 252 
 253 
5 Consequences of the chosen approach to diagnose malnutrition. 254 
 255 
Several problems may arise from the published consensus on “diagnostic criteria for malnutrition” 256 
(24). The consensus deviates from views expressed for decades in ESPEN (see 2. Definition of 257 
Malnutrition). In clinical practice the presence of inflammation is known to influence symptoms and 258 
function significantly. This has been taught in the ESPEN advanced and basic courses, has been 259 
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published in nutrition and general journals and is included in the ESPEN blue book (fourth 260 
edition)(20). Similarly, the consensus statement significantly deviates from views present in other 261 
parts of the world and developed in collaboration with ESPEN, and could cause confusion. Even more, 262 
countries and nutrition societies have in recent years come close to agreement on how to define 263 
malnutrition, underlining the role of nutrition and inflammation. This led in 2010 to the two parallel 264 
papers with authors from 5 continents that were published in the JPEN and Clinical Nutrition and 265 
endorsed by ASPEN and ESPEN (2, 3). In these papers an identical statement was given regarding the 266 
definition/pathophysiology of malnutrition as given in italics in the third definition in section “2. 267 
Definition of Malnutrition”. The present ESPEN Consensus Statement deviates significantly from the 268 
papers and the other ESPEN endorsed activities mentioned. Finally, in a recent consensus meeting in 269 
ASPEN, the views expressed by ESPEN representatives as described in the Cederholm et al paper (1) 270 
were qualified as a controversy with views expressed by representatives of ASPEN, PENSA and 271 
FELANPE.(Jensen GL. Global Leadership Conversation: Addressing Malnutrition. JPEN 2016 Mar 18)  272 
We must also realize that ESPEN has changed its name from reflecting artificial nutrition alone, to 273 
‘Clinical Nutrition and Metabolism’. Malnutrition is our main “disease” of interest and our practice 274 
will be handicapped when rejecting clinical and metabolic effects to be considered when diagnosing 275 
malnutrition. Only when we can adequately diagnose the cause and degree of malnutrition, 276 
quantitate the risk it carries for adequate host response, tissue function, growth and long term 277 
survival, establish priorities for treatment and offer adequate treatment, will we have more impact 278 
on clinical practice.  279 
6 Conclusions and Recommendations 280 
 281 
We suggest that the ESPEN community rethinks its views on how to define malnutrition and how 282 
to diagnose it. (see ways to diagnose malnutrition in Introduction; ref 1) The new statement may 283 
confuse the nutrition world. It is unsuitable to define treatment priorities and to predict effects of 284 
nutritional support.  285 
The essence of our argument is that malnutrition is a condition involving a nutritional status 286 
which is “mal”, that is bad for the patient in terms of impairing function and hence clinical outcome. 287 
It is therefore entirely appropriate, and indeed essential, that the diagnosis of malnutrition must 288 
include some aspect of function/clinical outcome. Cederholm has noted in his reply to a letter to the 289 
Editor (Mokaddem F. Clin Nutr.2016;35(1):237) that the consensus group required objective criteria 290 
for a diagnosis of malnutrition and that functional criteria are too non-specific. (Clin Nutr. 2016; 291 
35(1):237) The objective criteria we propose include an assessment of nutritional state and 292 
inflammation (by plasma CRP and albumin), which if present will impair function more than poor 293 
nutritional state alone. By linking inflammation only to cachexia, Cederholm et al have ignored the 294 
importance of inflammation in the vast majority of malnourished patients, who require to have their 295 
inflammation controlled before nutritional support can be fully effective. 296 
The participants of the consensus conference have not produced a set of criteria to diagnose 297 
malnutrition. They have produced a limited set of criteria to screen for malnutrition. Despite their 298 
stated intention, they note themselves that individuals identified by their criteria will require more 299 
detailed investigation to identify the subset with a true diagnosis of malnutrition, and with an 300 
understanding of the causes to ensure that appropriate treatment is commenced. They recommend 301 
first using a well-established screening tool such as NRS 2002, and then following this up with their 302 
diagnostic tool. Nowhere else in medicine when a disease is screened for using a number of tests, is 303 
the diagnosis confirmed by using only two of the same tests already included in the screening 304 
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procedure. To reach a diagnosis, more specific tests are needed than the screening criteria so that 305 
the screening data can be correctly interpreted.  306 
For this purpose consensus should be reached which techniques to use to diagnose malnutrition 307 
and to assess function, to predict the capacity to overcome the metabolic and nutritional burden of 308 
disease treatment and define priorities for treatment.  309 
A final recommendation regards nomenclature. In the consensus statement apparently no 310 
agreement was reached to use “undernutrition” or “malnutrition” to describe the malnourished 311 
state of our patients. In definition 3 in the subsection “3 Definition of Malnutrition” the term 312 
“malnutrition” is used for the state of nutrition of all our patients. The term “undernutrition” may 313 
then be used exclusively to indicate that the individual is or has been in a negative nutrient balance. 314 
We can opt to call such an individual “malnourished” but should specify that there is no or little 315 
accompanying inflammatory activity.  316 
In summary, we propose that ESPEN reconfirms its earlier position that the definition of 317 
malnutrition should contain the following elements:  318 
“Malnutrition is a state of disordered nutrition, in which a combination of varying degrees of over- 319 
or undernutrition and inflammatory activity has led to a change in body composition, diminished 320 
function and outcome.” 321 
Having agreed this definition, we recommend that tools be suggested and validated in different 322 
populations to make the diagnosis, based on the elements included in the definition.  323 
 324 
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Figure 1. Schematic representation of the diagnosis and treatment of malnutrition 
In the first column the chain of events is depicted leading from undernutrition/inflammation, to changes in body 
weight and composition along with functional disturbances. These elements jointly contribute to the risk of 
infection, inadequate wound healing, and increased mortality. In the second column cause/consequence 
relationships are listed. The art of investigation and clinical outcomes are described in the third column. The final 
column addresses treatment efficacy and adaptation to be employed in the case of initial failure. 
 
* Inflammation and undernutrition both lead to loss of fat free mass, but in subacute and severe inflammation, 
although body weight/ fat free mass may increase with nutritional treatment, fat free mass solids will not. 
 
# 
Energy demand decreases when physical activity decreases and generally increases in diseased and other 
inflammatory conditions. 
 
